Research Article
A Comparative Study of High-Dose Colistin Administration for the Management of Multidrug-Resistant Gram-Negative Infections in the ICU
Table 2
Clinical and microbiological response and toxicity comparison.
| | 9 MIU daily, n (%) | 3 MIU TDS, n (%) | Total, n (%) | value |
| Clinical response | 13 (76.5%) | 14 (77.8%) | 27 (77.1%) | 0.999 | Microbiological response | 8 (47.1%) | 11 (61.1%) | 19 (54.3%) | 0.404 | AKI | 4 (23.52%) | 8 (44.44%) | 12 (34.28%) | 0.193 | Time to increase Scr | 7 (7.5) | 4.5 (4.5) | | 0.283 | Time to response | 14 (3) | 14 (10) | 14 (6) | 0.720 |
|
|
Median day (IQR), AKI; acute kidney injury, IQR; interquartile range. |